Shenzhen Edge Medical Co., Ltd. (HKG:2675)
Hong Kong · Delayed Price · Currency is HKD 36.86
+2.18 (6.29%)
Sep 30, 2026, 4:08 PM HKT
Shenzhen Edge Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -18.77 | -88.61 | -218.51 | -212.87 |
Depreciation & Amortization | 25.36 | 25.63 | 28.28 | 16.94 |
Other Amortization | - | - | - | 1.93 |
Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 | 0.02 |
Asset Writedown & Restructuring Costs | - | - | 1.43 | - |
Loss (Gain) From Sale of Investments | -13.36 | -13.36 | -21.21 | -36.97 |
Loss (Gain) on Equity Investments | 0.09 | 0.09 | - | - |
Stock-Based Compensation | 28.14 | 28.14 | 40.03 | -13.66 |
Provision & Write-off of Bad Debts | 7.44 | 7.44 | 1.03 | 0.55 |
Other Operating Activities | -99.51 | -9.95 | -11.85 | -11.77 |
Change in Accounts Receivable | -0.99 | -0.99 | -11.53 | -0.7 |
Change in Inventory | -65.21 | -65.21 | 1.91 | -74.14 |
Change in Accounts Payable | 66.05 | 66.05 | 3.42 | 8.64 |
Change in Unearned Revenue | 15.25 | 15.25 | -16.24 | 25.54 |
Change in Other Net Operating Assets | -158.78 | -158.78 | -21.41 | -23.81 |
Operating Cash Flow | -214.29 | -194.29 | -224.64 | -320.31 |
Operating Cash Flow Growth | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -14.41 | -3.44 | -26.39 | -61.33 |
Sale of Property, Plant & Equipment | 0.14 | 0.14 | 0.06 | 0.02 |
Sale (Purchase) of Intangibles | -0.23 | -0.14 | -0.6 | -2.27 |
Investment in Securities | 323.39 | 172.23 | 221.46 | 445.41 |
Other Investing Activities | 12.24 | 1.66 | 1.71 | 1.91 |
Investing Cash Flow | 321.13 | 170.45 | 196.25 | 383.73 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Long-Term Debt Repaid | - | -7.15 | -6.97 | -7.39 |
Lease Payments | -8.55 | -7.15 | -6.97 | -7.39 |
Net Debt Issued (Repaid) | -67.74 | -7.15 | -6.97 | -7.39 |
Other Financing Activities | -32.12 | -2.18 | -0.38 | -1.8 |
Financing Cash Flow | 1,084 | -9.33 | -7.34 | -9.18 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -32.71 | -0.6 | 0.23 | 0.25 |
Net Cash Flow | 1,159 | -33.77 | -35.5 | 54.5 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -228.69 | -197.74 | -251.03 | -381.64 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | -36.55% | -43.39% | -156.90% | -794.39% |
Free Cash Flow Per Share | -0.61 | -0.55 | -0.70 | -1.06 |
Levered Free Cash Flow | -231.06 | -192.6 | -159.7 | - |
Unlevered Free Cash Flow | -230.53 | -192.26 | -159.16 | - |
Free Cash Flow After Leases | -237.25 | -204.89 | -258 | -389.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 0.85 | 0.54 | 0.86 | 0.99 |
Change in Working Capital | -143.68 | -143.68 | -43.85 | -64.48 |